Triad Group; Supplier shutting down the line that made tainted wipes
- File Under FDA, Triad Prep Pads
March 11
A Wisconsin medical supplier that made millions of recalled alcohol prep products now blamed for serious infections and at least one death is shutting down the line that produces the swabs and wipes — at least for now.
.The Triad Group of Hartland, Wis., plans to “move away” from its health care division, which produced contaminated alcohol pads and lubricating jelly, and focus instead on its private label and contract brands, according to an internal letter obtained by msnbc.com...
.
FDA logs 161 reports about alcohol wipes Since the recall, the FDA has received 161 reports of adverse events related to alcohol prep wipes, including three deaths, which don’t appear to be related to Triad products, Burgess said. Perdue said his firm has been contacted by more than 100 people reporting infections tied to the wipes.
Roche said "Triad pads are distributed with several drugs including the Boniva bone-building drug and hepatitis C treatment Pegasys."
Merck said "Triad pads were distributed with Pegintron, a treatment for hepatitis C, and a related drug, Intron A, outside the U.S. Merck said drugs distributed in the U.S. aren't affected."
Merck issued a warning about the recalled pads to customers who use Pegintron (peginterferon alfa-2b) single dose RediPen and Pegintron vials for markets in Europe, Asia Pacific (excluding Japan), Latin America and Canada, and Intron A (interferon alfa-2b) Multidose RediPen and Intron A solution vials for markets in Europe, Asia Pacific (excluding Japan) and Latin America.
Merck said "Triad pads were distributed with Pegintron, a treatment for hepatitis C, and a related drug, Intron A, outside the U.S. Merck said drugs distributed in the U.S. aren't affected."
Merck issued a warning about the recalled pads to customers who use Pegintron (peginterferon alfa-2b) single dose RediPen and Pegintron vials for markets in Europe, Asia Pacific (excluding Japan), Latin America and Canada, and Intron A (interferon alfa-2b) Multidose RediPen and Intron A solution vials for markets in Europe, Asia Pacific (excluding Japan) and Latin America.
.
.
FDA defends actions on tainted wipes
Problems with contamination and sterilization at a Wisconsin plant that made millions of recalled alcohol wipes did not rise to the level of a public health hazard — until a hospital detected potentially life-threatening bacteria.
FDA defends actions on tainted wipes
Problems with contamination and sterilization at a Wisconsin plant that made millions of recalled alcohol wipes did not rise to the level of a public health hazard — until a hospital detected potentially life-threatening bacteria.
...
0 comments: